DELCF News and Press, Delic Holdings From 04/26/22

SRAX (NASDAQ: SRAX) , a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, hosted the 2022 Cannabis and Psychedelic Conference, a preeminent virtual investor event, on April ...

Delic Holdings Corp operates in North America to advance the use of psychedelics in treating difficult conditions related to major depression, PTSD and anxiety The company has a three-pronged approach to promoting access and affordability for treatment drugs: conducting research in its ...

Over the past couple of years, there has been increased interest in psychedelics as alternative treatments for mental disorders. With most mental health medications causing side effects such as muscle spasms, nausea, constipation and loss of sex drive, there has been a push for safer alter...

Delic Labs just received its Health Canada 56 Research Exemption, enabling it to develop innovative analytical methods for psychedelic research The company first applied for the exemption in October 2021, along with a Dealer’s License for commercializing psilocybin research and a...

Last week, legislators in Maryland advanced a measure to the governor that would establish a state fund to provide access to psychedelic drugs such as ketamine, MDMA and psilocybin free of charge to veterans suffering from traumatic brain injury and post-traumatic stress disorder (PTSD). ...

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) , a leader in new medicines and treatments for a modern world, today announced that its co-founder and CEO Matt Stang will participate at the Sequire Cannabis and Psychedelic Conference and the Scottsdale Capital Event . Stang will pre...

Delic Corp to Participate at Sequire Cannabis and Psychedelic Conference and Scottsdale Capital Event Canada NewsWire Matt Stang , Co-founder and CEO of Delic Corp, will present on the Company's strategic outlook for the remainder of the year at the Sequire Cannabi...

Delic opened two new KWC clinics in Q1 2022, bringing the total number of locations to 13, with plans to open more within the next 18 months The company also saw the introduction of SPRAVATO(R) nasal spray as a treatment option for treatment-resistant depression It is also expanding i...

A new study has found that psilocybin causes temporary changes to the basic structural organization of normal sleep in lab mice. Professor Vladyslav V. Vyazovskiy of the University of Oxford, who conducted the study, stated that evidence had shown that psychedelics such as psilocybin could...

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, and its subsidiary Delic Labs have received a Health Canada 56 Research Exemption. The exemption gives approval for the company to conduct research and perform tests on severa...